Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 634
Recruiting: 364
Ph III recruiting: 20
Growth YoY: −14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06617572	Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel	available	—	—	USWM CT, LLCINDUSTRY	1	Aug 11, 2026	clinicaltrials
NCT06751524	Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval	available	—	—	Agenus Inc.INDUSTRY	0	May 15, 2026	clinicaltrials